Paul Burke retweeted
#Breaking: Health secretary RFK Jr. shuts door on U.S. investment in mRNA vaccine research
statnews.com/2025/08/05/mrna…
Paul Burke retweeted
Use of GalNAc-based liver targeting to improve the safety profile of an effective small molecule. The result of a terrific collaboration between the non-profit, academic, and industrial sectors ==>>
@gatesfoundation @UWMolES @UWBioE
science.org/doi/10.1126/scia…
Use of GalNAc-based liver targeting to improve the safety profile of an effective small molecule. The result of a terrific collaboration between the non-profit, academic, and industrial sectors ==>>
@gatesfoundation @UWMolES @UWBioE
science.org/doi/10.1126/scia…
Paul Burke retweeted
RNA-editing drugs advance into clinical trials bit.ly/445OqZV
ADAR-based editors that can change the mRNA code offer new opportunities in both rare genetic diseases and common complex ones. Find out more in this news article published today
Three cheers for intact TLR9 inflammatory signalling!
Love the cross-talk between development and innate defenses. Examples include antiviral RNAi being repurposed for developmental miRNA biology, or conversely, developmental TLRs being repurposed for defense. Now we see TLR9 also contributing to memory rdcu.be/dCHcO"
2
322
Novo's giant bet on ncRNA =>
statnews.com/2024/03/25/novo… via @statnews
195
Paul Burke retweeted
Delivery, delivery, delivery!
Join us in Siracusa, Italy from April 4-7 to discuss new advances in nucleic acid delivery and how to solve the remaining challenges! Don't miss this opportunity. Abstract deadline is March 15, 2024. Register here:
engconf.us/conferences/biote…
Paul Burke retweeted
We are excited to share our views on extra-hepatic delivery in @NatureNano. Congrats to all our exceptional team members who did most of the heavy lifting and the editorial team and reviewers for their feedback!
Happy New Year and Happy Reading!
nature.com/articles/s41565-0…
Paul Burke retweeted
#Breaking: The U.S. FDA approves the CRISPR/Cas9 gene-edited treatment, co-developed with Vertex Pharmaceuticals, for #SickleCellDisease. Learn more: bit.ly/4apMw9p
Approval of Casgevy, from Vertex and CRISPR Therapeutics => nature.com/articles/d41586-0…
2
249
“A new Nature series will explore the many ways in which artificial intelligence is changing science — for better and for worse.”
nature.com/articles/d41586-0…
204
If you use the @wsj App and have not recently updated it, DON’T DO IT!!! It is the New Coke of iPad Apps. And it appears there is no way to roll back to the earlier version.😠
Replying to @WSJ
@WSJ We're happy to share we’ve reintroduced beloved features, and new enhancements, to optimize the WSJ iPad experience. Update your WSJ mobile app to enjoy these offerings now, including the reintroduction of our vertical What’s News layout. More updates will be coming soon!
2
3
544
Alnylam’s experimental Alzheimer’s RNAi therapy cut disease-linked proteins by 65% for six months – Endpoints News endpts.com/single-injection-…
3
546
Novo Nordisk's oral semaglutide on par with injectable version in weight loss and safety - endpts.com/novo-nordisks-ora…
300
“The bottleneck used to be the science and finding drugs,” says one physician. “The new bottleneck is having enough people trained to give them.” @AmyDMarcus #antisense wsj.com/articles/these-drugs…
218
Paul Burke retweeted
It’s a big mistake to weigh commercial opportunity (often done by 25 yo consultants) over likelihood of patient impact (usually done with gray hair and wrinkle)…. Just saying!
Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing | Nature Biotechnology nature.com/articles/s41587-0…
11
1,940
Promise of superhero status makes injections acceptable!
“As influencers share stories of physiological transformations, more people are seeking out experimental treatments: ‘If I can be a superhero and function at my absolute optimum, why wouldn’t I?’” wsj.com/articles/peptide-inj…
1
380
Looking forward to digging into this, recently posted from @wittrup_anders lab =>
nature.com/articles/s41467-0…
4
456














